-----------------------------------------------------------
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2002
--------------------------------------
CELESTICA INC.
(TRANSLATION OF REGISTRANT'S NAME INTO ENGLISH)
--------------------------------------
12 CONCORDE PLACE
TORONTO, ONTARIO
CANADA, M3C 3R8
(416) 448-5800
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F X Form 40-F ______
------
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes _____ No X
-------
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82-_________
-----------------------------------------------------------------------------
CELESTICA INC.
FORM 6-K
MONTH OF MAY 2002
Filed with this Form 6-K are the following, which are incorporated herein by
reference:
- Management's Discussion and Analysis of Financial Condition and Results
of Operations for the three months ended March 31, 2002.
- Consolidated Financial Statements of Celestica Inc. for the three
months ended March 31, 2002.
Exhibits
--------
99.1 - Management's Discussion and Analysis
99.2 - Consolidated Financial Statements
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
CELESTICA INC.
Date: May 3, 2002 BY: /s/ Elizabeth L. DelBianco
----------------------------
Name: Elizabeth L. DelBianco
Title: Vice President & General Counsel
EXHIBIT INDEX
-------------
EXHIBIT DESCRIPTION
------- -----------
99.1 Management's Discussion and Analysis
99.2 Consolidated Financial Statements